Usk Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in Kadugodi, Karnataka, India, established in 2021.
2021 Kadugodi, Karnataka, India Active
Last Updated:
Access Report
About Usk Therapeutics Private Limited

Usk Therapeutics Private Limited, a active private limited company, was established on 27 September 2021 in Kadugodi, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290KA2021PTC152293. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Employing 25 professional, Its leadership includes Sadu Kameswari (Managing Director), Sobha Velamuru (Director), Katakam Ushasree (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No 102, 1St Floor, Sv Elegant Syno.2/1 & 2/7,Kumbena Agrahara,Belathur, Kadugodi, Karnataka, 560067.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290KA2021PTC152293

  • Registration Number

    152293

  • Incorporation Date

    27 September 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 4 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 211.69%
  • Ebitda **** 255.79%
  • Net Worth 274.49%
  • Total Assets **** 441.72%
Company report

Usk Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Usk Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Usk Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sadu Kameswari Managing Director 27 Sep 2021 Current
Sobha Velamuru Director 27 Sep 2021 Current
Katakam Ushasree Director 27 Sep 2021 Current
Puchalapalli Sankeerthi Director 27 Sep 2021 Current
Ramakrishna Reddy Madakala Director 27 Sep 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Usk Therapeutics.

Usk Therapeutics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 211.69% increase in profit. The company's net worth Soared by an impressive increase of 274.49%.

Usk Therapeutics revenue growth over time
Usk Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 441.72%
*******
*******
*******
*******
Profit or Loss
*******
 211.69%
*******
*******
*******
*******
Net Worth
*******
 274.49%
*******
*******
*******
*******
EBITDA
*******
 255.79%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Usk Therapeutics?

In 2023, Usk Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Usk Therapeutics?

Unlock and access historical data on people associated with Usk Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Usk Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usk Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Usk Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Usk Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Usk Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    Sadu Kameswari was appointed as a Managing Director was appointed as a Managing Director on 27 Sep 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.

  • Director Appointment

    Sobha Velamuru was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.

  • Director Appointment

    Katakam Ushasree was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Puchalapalli Sankeerthi was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Usk Therapeutics Private Limited?

The CIN of Usk Therapeutics Private Limited is U24290KA2021PTC152293.

Where is Usk Therapeutics Private Limited headquartered?

Usk Therapeutics Private Limited is headquartered at Flat No 102, 1St Floor, Sv Elegant Syno.2/1 & 2/7,Kumbena Agrahara,Belathur, Kadugodi, Karnataka, 560067.

When was Usk Therapeutics Private Limited incorporated?

Usk Therapeutics Private Limited was incorporated on 27 September 2021.

Who are the current directors of Usk Therapeutics Private Limited?

The current directors of Usk Therapeutics Private Limited are

What is the primary industry of Usk Therapeutics Private Limited?

The primary industry of Usk Therapeutics Private Limited is Manufacturing.

Is Usk Therapeutics Private Limited a listed company?

Usk Therapeutics Private Limited is unlisted.

What is the capital structure of Usk Therapeutics Private Limited?

The authorized capital of Usk Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available